Human immunoglobulin (Shenzhen Weiguang)

人免疫球蛋白（深圳卫光）

Report date: 2026/03/17 20:00:15

Base Information

Drug NameHuman immunoglobulin (Shenzhen Weiguang)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Blood components
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPrimary Immunodeficiency DiseasesPurpura, Thrombocytopenic, IdiopathicMeasles +[4] 
Global Approved IndicationsMeaslesHepatitis, Viral, Human
Approved Indications in ChinaMeaslesHepatitis, Viral, Human
Original Approved Country/TerritoryMainland China
Original Approved Date1999/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenzhen Weiguang Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Weiguang Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsPrimary Immunodeficiency DiseasesPurpura, Thrombocytopenic, IdiopathicMeasles +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG